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 7 
ABSTRACT 8 
Aim Since both mineral trioxide aggregate (MTA) and fluoride are widely recognized for 9 
their hard tissue-inductive properties, the present study aimed to investigate if a combination 10 
of both compounds affects bone cells. 11 
Methodology MTA disks (ProRoot®, Dentsply, Germany) with and without addition of 12 
0.1%, 0.25%, and 0.5% sodium fluoride were characterized for their surface roughness by 13 
laser scanning microscopy and for the adhesion of human alveolar osteoblasts by scanning 14 
electron microscopy. Using eluates from fluoride-enriched MTA disks, the cell proliferation 15 
was measured by monitoring the DNA incorporation of 5-bromo-2'-deoxyuridine. Further, 16 
gene expression was evaluated by qPCR arrays, extracellular matrix mineralization was 17 
quantified by absorption measurement of Alizarin red stains, and effects were calculated with 18 
repeated measures analysis and post hoc p-value adjustment. 19 
Results Irrespective of fluoride addition, cell adhesion was similar on MTA disks, of which 20 
the surface roughness was comparable. Control osteoblasts had a curvilinear proliferation 21 
pattern peaking at d5, which was leveled out by incubation with MTA. The addition of 22 
fluoride partly restored the MTA-related reduction of the cellular proliferation rate in a dose-23 
dependent manner. At the mRNA level, both fluoride and MTA modulated a number of genes 24 
involved in osteogenesis, bone mineral metabolism and extracellular matrix formation. 25 
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Although MTA significantly impaired extracellular matrix mineralization, the addition of 1 
fluoride supported the formation of mineralized nodules in a dose-dependent manner.   2 
Conclusion The addition of fluoride modulated the biocompatibility of MTA in terms of 3 
supporting bone cell proliferation and hard tissue formation. Hence, fluoride enrichment is a 4 
trend-setting advancement for MTA-based endodontic therapies. 5 
 6 
Introduction 7 
Mineral trioxide aggregrate (MTA) fulfills the prerequisites of an endodontic repair material, 8 
i.e. adhering to tooth hard tissues and providing sufficient seal while being stable, radiopaque 9 
and biocompatible (Roberts et al. 2008). The major components of hygroscopic MTA are 10 
tricalcium silicate, tricalcium aluminate, calcium silicate and tetracalcium aluminoferrite (Lee 11 
et al. 2004, Nekoofar et al. 2011, Grazziotin-Soares et al. 2017). Upon mixing with water, the 12 
cement powder hydrates to form a poorly crystallized silicate gel (Camilleri & Pitt Ford 13 
2006). The most intensely studied characteristics of MTA include its chemical, physical, anti-14 
leakage and biocompatibility properties, and in this regard, MTA was reported to promote 15 
calcified barrier formation with low inflammatory response if used for root perforation repair 16 
or vital pulp therapies, respectively (Roberts et al. 2008, Tawil et al. 2015). 17 
Currently, research interest focuses on modifying the MTA composition with the aim of 18 
improving the physical (Lee et al. 2011), antimicrobial (Schmalz & Galler 2017) or  handling 19 
properties (Kogan et al. 2006). However, little attention has been paid so far to the 20 
biocompatibility testing of MTA supplied with additives (Karygianni et al. 2016), which 21 
furthermore have not been selected according to their cell- or tissue-supporting capabilities. 22 
Such additives would ideally (i) foster bone and/or pulp cell proliferation and differentiation, 23 
and hence increase hard tissue formation, while simultaneously (ii) being non-toxic and 24 
legally approved as a drug, and (iii) exerting antimicrobial actions. All of these requests are 25 
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met by fluoride (Everett 2011, Lee et al. 2017), thus rendering it an attractive candidate for 1 
the development of a new MTA cement (Gandolfi & Prati 2010, Gandolfi et al. 2011). 2 
Fluoride is reported to enhance bone mass and increase the stability of calcified tissues in 3 
vivo, while encouraging proliferation and osteogenic differentiation in a dose-dependent 4 
manner at the cellular level (Everett 2011). Since adequate hard tissue formation is the most 5 
challenging issue in endodontics, it is appealing to assess whether the enrichment of MTA 6 
with fluoride enhances the performance of hard tissue-forming bone cells. Hence, the aim of 7 
this study was to test the behaviour of primary human osteoblasts derived from the alveolar 8 
bone in response to fluoride-enriched MTA. The null hypothesis was that fluoride addition to 9 
MTA improves the adhesion, proliferation and differentiation of alveolar osteoblasts in terms 10 
of gene expression, matrix mineralization and alkaline phosphatase activity. 11 
 12 
Material and Methods 13 
MTA disk and eluate production 14 
White Pro Root MTA powder (0.1g each; Dentsply, Konstanz, Germany) was mixed with 15 
sterile H2O (35µl) enriched with 0.5%, 0.25%, 0.1%, which was previously checked to release 16 
7.5×10-5M , 1.7×10-5M or 0.9×10-5M fluoride (Merck, Darmstadt, Germany), respectively (data 17 
not shown); cement pellets without sodium fluoride addition served as controls. The cement 18 
mixtures were transferred into inverted plastic lids of Eppendorf microtubes and allowed to 19 
set for 24 h in a humidified atmosphere. The solid cement disks (0.5 cm2 surface area, height 20 
1.5 mm) were rinsed with 70% ethanol, washed with phosphate-buffered saline (Life 21 
Technologies, Darmstadt, Germany) and exposed to UV light under the Laminar Flow. For 22 
eluate preparation according to ISO 10993-5, MTA disks were placed for 72h in 1mL serum-23 
free growth medium each supplemented with  1% glutamine (both Life Technologies GmbH) 24 
and 0.2% kanamycin (Sigma-Aldrich, Taufkirchen, Germany), and stored at -80 °C. 25 
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 1 
Cell culture 2 
All experiments were carried out in accordance to the guidelines of the World Medical 3 
Association Declaration of Helsinki and were approved by the Committee of Ethics of the 4 
Medical Faculty of the Albert Ludwigs-University Freiburg, Germany (EK-153/15). 5 
Osteoblasts were isolated as described elsewhere (Proksch et al. 2015). Briefly, alveolar bone 6 
biopsies were minced and plated as explants in Dulbecco’s Modified Eagle’s medium 7 
(DMEM, LifeTechnologies) supplemented with 10% foetal bovine serum (Biochrom, Berlin, 8 
Germany), 1% glutamax (LifeTechnologies) and 1% antibiotics (Sigma Aldrich, Munich, 9 
Germany) until cell outgrowth, and cells were expanded by splitting up to 4-6 times. For 10 
analyses, cells were serum-deprived for 24h before incubation with MTA-eluate medium. Cell 11 
culture conditions were as follows: for SEM analysis, 1×104 cells/MTA disk in 96-well 12 
microtiter plates for 7d, for proliferation evaluation, 1×104 cells/well in 96-well microtiter 13 
plates for 1, 3, 5, and 7d, for gene expression analysis, 1×104 cells/cm2 in T25 culture flasks 14 
for 7d, and for Alizarin red staining, 5×104 cells/well in 48-well multiwell plates for 21d. 15 
 16 
Laser scanning microscopy 17 
MTA disks were analysed using a confocal 3D laser scanning microscope (VK-X200K, 18 
Keyence Corp., Neu-Isenburg, Germany) at 20× magnification. Six regions of interest (0.04 19 
mm2 each) were analysed for each sample (n=5 per group) with tilt correction according to JIS 20 
B0601:2001 (ISO 4287:1997) using the VK analyzer software v3.5.0.0 (Keyence Corp.). 21 
 22 
Scanning electron microscopy 23 
The specimens were fixed in 4% formaldehyde and dehydrated in an ascending ethanol series 24 
(50%, 70%, 80%, 90% once each and twice in 100% for 1h). Afterwards, critical point drying 25 
(Critical Point Dryer CPD 030; Bal-Tec, Wallruf, Germany) was performed, and the samples 26 
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were sputter-coated with a gold palladium for 60s at 60mA (SCD 050; Bal-Tec) and scanned 1 
by a Zeiss Leo 435 VP scanning electron microscope at 10 kV (Zeiss, Oberkochen, 2 
Germany). 3 
 4 
Proliferation assay 5 
Newly synthesized DNA was measured by using a cell proliferation ELISA kit (Roche, 6 
Mannheim, Germany) according to manufacturer’s instructions. In brief, cells were fixed with 7 
a one-step ready-to-use solution for 30 min at RT, and a peroxidase (POD)-labelled anti-BrdU 8 
antibody was added (1:100, 90 min, RT). The immune complexes were detected by adding 9 
tetramethyl-benzidine (30 min, RT), and the substrate reaction was stopped by adding 1 M 10 
H2SO4 (1:5) and quantified by measuring the absorbance at 450 nm (reference wavelength 690 11 
nm). 12 
 13 
qPCR 14 
Gene expression was monitored using the RT2Profiler PCR Array technology (Qiagen, Hilden, 15 
Germany). Total cellular RNA was purified using a guanidium–thiocyanate method (RNeasy 16 
Mini kit; Qiagen) and stored at -80 °C. The RNA integrity and quantity were verified using 17 
the Experion RNA StdSens chip microfluidic technology (Bio-Rad, Munich, Germany). After 18 
genomic DNA elimination and reverse transcription using the RT2 PreAmp cDNA synthesis 19 
kit (Qiagen), one quarter of the resulting cDNA was pre-amplified using the RT2 PreAmp 20 
Pathway Primer Mix (Quiagen). qPCR was performed in duplicate each in a CFX96 cycler 21 
(Bio-Rad), according to the manufacturer’s instructions. Genomic DNA contamination, 22 
reverse transcription performance and purity, and qPCR efficiency were routinely checked. 23 
The amplicons’ specificity was checked by melting curve examination. Data were collected 24 
with CFX96 Manager Software version 1.0 (Bio-Rad), and the respective genes of interest 25 
were normalized to a housekeeping gene pool comprising ACTB, RPL0, B2M, and HPRT. 26 
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Data were analyzed and plotted using the RT2 Profiler PCR array data analysis template 1 
(http://pcrdataanalysis.sabiosciences.com/ pcr/arrayanalysis). For discriminating MTA- and 2 
fluoride-related effects, the gene expression in the non-fluoride MTA group was compared to 3 
MTA-free controls. In addition, the gene expression in the respective fluoride groups was 4 
compared both to MTA-free controls and to the non-fluoride MTA group. 5 
 6 
Alizarin red staining and extraction 7 
Cells were incubated with 40 mM Alizarin red solution (Sigma Aldrich, pH 4.1) for 20 min at 8 
RT. After thorough washing, the air-dried specimens were evaluated with a SZH10 9 
microscope (Olympus, Münster, Germany) equipped with a CCD Colour view III camera, and 10 
images were taken and analyzed using the Cell* software (both Olympus). For quantification, 11 
Alizarin red was extracted with 10 % acetic acid (30 min, RT). The solution was incubated for 12 
10 min at 85 °C and the absorbance of the supernatant was read at 420 nm in triplicate. Data 13 
were collected and analyzed using the Magellan v6.2 software (Tecan, Crailsheim, Austria). 14 
 15 
Statistical analysis 16 
A repeated measures analysis was performed with a linear mixed model for each outcome of 17 
interest (BrdU incorporation, mM Alizarin red). The group effects and differences of least 18 
square means (LSM) were calculated with their 95-% confidence intervals. Several multiple 19 
comparisons of LSM in group and time combinations were performed and p-values were 20 
adjusted for multiple testing by the method of Dunnett, Tukey-Kramer or Scheffe, 21 
respectively. All calculations have been done using PROC MIXED/xtmixed from the 22 
statistical software SAS 9.1.2 (Cary, NC 27513, USA)/STATA 14.2. 23 
 24 
 25 
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Results 1 
Osteoblasts adhere to MTA disks of comparable surface roughness 2 
irrespective of fluoride addition 3 
Non-fluoride MTA had a mildly granular surface, which became obvious from a narrow range 4 
of profile values (Fig. 1a,b). This finding also applied for fluoride-enriched MTA, with 0.25% 5 
fluoride yielding a broader profile value range (Fig. 1a,b). This higher granularity was 6 
opposed to the trend of 0.1 and 0.5% fluoride to smoothen the surface (Fig. 1b). In 7 
consequence, vertical texture parameters significantly differed in the 0.25% group compared 8 
to the 0.5% fluoride group (Sp: p=0.034, Sv: p=0.018, Sz: p=0.006, Sa: p=0.016, Sq: p=0.015), 9 
while horizontal texture parameters were similar (Fig. 1b). Nevertheless, regardless of 10 
fluoride addition, the osteoblasts attached readily to MTA and formed a continuous cell layer 11 
at 7d (Fig. 1a). For all groups, the cells had a regular morphology with a blurred appearance 12 
of the cell borders (Fig. 1a). The cells exhibited a plane, triangular to rectangular shape while 13 
lacking extremely long and spindle-like cell extensions. Together, despite some roughness 14 
disparities, the cell adhesion and morphology were similar for all MTA groups irrespective of 15 
fluoride enrichment.  16 
 17 
MTA decreases and fluoride restores the proliferation of bone cells 18 
MTA-free control osteoblasts had a peak-to-valley proliferation pattern with initially low 19 
values that significantly increased at 5d (p<0.0001 both for 1d and 3d vs. 5d) before 20 
significantly decreasing at 7d (p<0.0001 5d vs. 7d) while still having twice the BrdU uptake 21 
of 3d (p=0.0199 3d vs. 7d, Fig. 2a). However, incubation with MTA eluates cleared the peak-22 
to-valley proliferation pattern, and additionally decreased the overall cellular BrdU uptake. In 23 
detail, the proliferation of osteoblasts incubated with eluates from non-fluoride MTA did not 24 
increase at 5d and was close to zero at 7d (p=0.0501 1d vs. 7d, Fig. 2a). Of note, the 25 
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enrichment of MTA with fluoride partly restored the MTA-related reduction of the cellular 1 
proliferation rate in a dose-dependent manner. At 1d, osteoblasts incubated with eluates from 2 
0.5% fluoride-MTA proliferated significantly more than non-fluoride MTA cells (p=0.0106, 3 
Fig. 2b). In all fluoride-enriched MTA groups, the BrdU uptake was significantly increased at 4 
1d and 5d compared to 7d (p=0.0034 1d vs. 7d and p=0.0149 5d vs. 7d for 0.1% fluoride; 5 
p=0.0070 1d vs. 7d and p=0.0042 5d vs. 7d for 0.25% fluoride, and p=0.0094 1d vs. 7d and 6 
p=0.0507 5d vs. 7d for 0.5% fluoride, respectively, Fig. 2a). Although the 0.5% fluoride 7 
group proliferated significantly more at 7d compared to the 0.1% group (p=0.0334, Fig. 2b), 8 
the proliferation was significantly lower at 5d and 7d for all MTA groups compared to MTA-9 
free controls (p<0.0001 each, Fig. 2b), irrespective of fluoride enrichment.  10 
 11 
Both MTA and fluoride enrichment modulate the osteogenic mRNA 12 
transcription 13 
Several MTA-related, fluoride-related and combined effects became obvious from the gene 14 
expression profiles of osteoblasts incubated with non-fluoride MTA compared to MTA-free 15 
cells (Fig. 3) and of the respective fluoride groups compared to both controls (Fig. 4). MTA 16 
incubation resulted in an up-regulation of ALPL, BMP2, BMP3, BMPR1B, MMP10, NOG, 17 
SMAD1, and a down-regulation of COL15A1, FGF1, GDF10, MMP9, SERPINH1, SPP1 and 18 
VCAM1 (Figs. 3 and 4). The addition of fluoride increased the transcription of CTSK, while 19 
COMP, FGFR2 and IGF1 were decreased (Figs. 3 and 4). Mutually intensifying effects 20 
became obvious for MTA and fluoride addition with regard to AHSG, BGN, BMP7, FLT1, 21 
PHEX, TGFB2 and VDR, while the two substances contrarily affected the transcription of 22 
CHRD, EGF, IGF2, SMAD4, SP7 and TWIST1 (Figs. 3 and 4). Although VEGFB was up-23 
regulated in cells incubated with eluates from the 0.1% (Fig. 4a) and the 0.25% fluoride-MTA 24 
group (Fig. 4b), this effect became significant only in the 0.5% fluoride group compared to 25 
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MTA-free controls (p=0218, Fig. 4c). Moreover, high-dose fluoride enrichment modulated 1 
the expression of BGLAP, BGN, COL10A1, FN1, ICAM1, RUNX2, and VEGFA, while further 2 
dose-related effects were visible for ITGA2 and, again, SPP1 (Figs. 3 and 4). CD36 was up-3 
regulated in all fluoride-enriched groups relative to MTA-free controls (Fig. 4a-c), while 4 
being unchanged compared to the non-fluoride MTA group (Fig. 4d-f), and if comparing the 5 
non-fluoride MTA group to MTA-free controls (Fig. 3a,b). This finding points to a combined 6 
effect of MTA and fluoride that is not noticeable for either of them alone. For the 7 
transcriptome profiling, all genes with a fold regulation change >|1.5| were taken into account 8 
for analysis, while admittedly rather expression changes >|2| are considered biologically 9 
meaningful. Nevertheless, the mRNA quantity of some genes with expression changes <|2| 10 
was modulated in a statistically significant way, while genes showing expression modulation 11 
up to |8| did not reach the mathematical significance level. Hence, expression changes of large 12 
magnitudes, as seen for COMP, COL15a1, IGF1, MMP10, MMP9, and NOG, are supposed to 13 
influence a biological system even if they appear non-significant. Together, MTA-related 14 
effects became visible mainly for mRNAs relevant for osteogenic differentiation and 15 
extracellular matrix formation, and the latter group was also mostly influenced by dose-16 
dependent fluoride effects. 17 
 18 
Fluoride enhances the MTA-impaired extracellular matrix mineralization 19 
The modulation of the transcriptome profile both by MTA and fluoride led the investigation 20 
of the extracellular matrix mineralization, which is regarded as the hallmark of osteogenic 21 
differentiation and the ultimate prerequisite for hard tissue restoration. Compared to MTA-22 
free controls (Fig. 5a), incubation with eluates from non-fluoride MTA (Fig. 5b) significantly 23 
reduced matrix calcification (p<0.0001). The same applied for osteoblasts incubated with 24 
eluates from MTA enriched with 0.1% (Fig. 5c, p<0.0001), 0.25% (Fig. 5d, p<0.0001), and 25 
0.5% fluoride (Fig. 5e, p<0.0001, Fig. 5f). However, the addition of fluoride essentially 26 
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supported matrix mineralization in a dose-dependent manner. Similar to the non-fluoride 1 
MTA group, the 0.1% fluoride-MTA group was not associated with noteworthy calcium 2 
deposits. However, osteoblasts incubated with 0.25% fluoride-MTA had significantly more 3 
Alizarin red staining compared both to non-fluoride MTA (p=0.0022, Fig. 5f) and compared 4 
to 0.1% fluoride-MTA (p=0.0058, Fig. 5f). The amount of dye was even increased in the 5 
0.5% fluoride group (p=0.0006 vs. non-fluoride MTA and p=0.0017 vs. 0.1% fluoride-MTA, 6 
Fig. 5f). 7 
 8 
Discussion 9 
Mineral trioxide aggregate is considered the gold standard therapeutic agent for hard tissue 10 
induction purposes (Karygianni et al. 2016, Lv et al. 2017). The results of the present study 11 
reveal that the enrichment of ProRoot MTA with fluoride improves its biocompatibility in 12 
terms of osteoblast proliferation, osteogenic gene expression and extracellular matrix 13 
mineralization, while the cement texture modifies neither the cell adhesion nor morphology. 14 
Basically, tissue cells react to their environment, i.e. the presence of fluoride-enriched 15 
ProRoot MTA, by (i) focal adhesion-mediated processing of biomechanical signals and (ii) 16 
perception of eluted biomolecules (Engler et al. 2009). For biomechanical sensing, osteoblasts 17 
seize the elasticity and topology of MTA by anchoring to the cement via focal adhesion sites 18 
(Giancotti & Ruoslahti 1999, Fletcher & Mullins 2010), which facilitate the reciprocal 19 
transformation of biomechanical to biochemical signals (Tomakidi et al. 2014). Generally, the 20 
physical properties of solidified MTA largely rely on handling parameters such as 21 
powder/liquid ratio (Basturk et al. 2015), mixing method (Nekoofar et al. 2010, Basturk et al. 22 
2014, Duque et al. 2018), condensation pressure (Nekoofar et al. 2007), environmental 23 
humidity (Caronna et al. 2014, Shokouhinejad et al. 2014) and pH (Bolhari et al. 2014), all 24 
being constant in the experimental setup. From a chemical viewpoint, mixing the MTA 25 
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powder with fluoride-enriched water is assumed to result in chemical integration of fluoride 1 
into the solidifying crystal structures (Song et al. 2006, Parirokh & Torabinejad 2010), which 2 
probably sustains physical characteristics similar to non-fluoride ProRoot MTA (Appelbaum 3 
et al. 2012). Hence, the elasticity of fluoride-enriched MTA is supposed to be in the range of 4 
non-fluoride MTA (Haecker et al. 2005). Since the order of magnitude manipulating cellular 5 
lineage specification (Engler et al. 2006) is far below, the changes resulting from fluoride 6 
addition to MTA might be irrelevant for bone cells. Regarding topographical cues, it can be 7 
speculated that 0.25% fluoride modulates the size of MTA crystals during the hydration 8 
process (Camilleri 2007). Nevertheless, regardless of any roughness disparities, the adherent 9 
bone cells were similar in shape and number. Although it cannot be ruled out that topological 10 
cues may affect bone cell behavior (Iskratsch et al. 2014), this finding suggests that 11 
investigating the cellular responses to biochemical signals as a function of fluoride 12 
enrichment appears more compelling in the first place. As a consequence, it was decided to 13 
focus on the analysis of eluate-related, i.e. biochemically induced rather than adhesion-related 14 
effects of MTA with and without fluoride addition. 15 
In fact, two main points became obvious from eluate testing: first, ProRoot MTA itself 16 
decreased proliferation and extracellular matrix formation of alveolar osteoblasts, and scores 17 
of genes involved in osteogenesis, bone mineral metabolism and extracellular matrix 18 
formation were modulated. Second, the addition of fluoride supported the bone cell 19 
proliferation and matrix calcification, and modulated the transcription of COMP, CTSK, IGF1 20 
and FGFR2 independently from MTA-related effects, while further genes were regulated in a 21 
dose-dependent manner in response to the ProRoot MTA presence. The finding that ProRoot 22 
MTA delayed both bone cell proliferation and differentiation seems surprising because it is 23 
widely accepted that MTA is highly biocompatible (Camilleri & Pitt Ford 2006, Lv et al. 24 
2017) and supports hard tissue formation (Parirokh & Torabinejad 2010, Katsamakis et al. 25 
2013). However, the term ‘biocompatibility’ in general refers to the degree of a material’s 26 
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toxicity, which is usually measured by means of phenotyping, monitoring the inflammatory 1 
response or the metabolic activity of target cells, while behavioral parameters such as cell 2 
division or differentiation are not addressed. Actually, a number of reports show that cellular 3 
proliferation and differentiation are diminished by MTA if compared to native controls 4 
(Nakayama et al. 2005, Hakki et al. 2009, Willershausen et al. 2013, Suzuki et al. 2015); and 5 
it’ is not surprising that cells in contact with any repair material perform worse compared to 6 
untouched controls. A subtle but important difference is that MTA indeed supports the 7 
cellular performance if compared to other endodontic materials (Nakayama et al. 2005), 8 
which were not investigated in the framework of this study. Hence, the present data do not 9 
conflict with MTA being biocompatible and tissue-supportive. 10 
Fluoride improved the MTA-altered cell behavior by proliferation enhancement and 11 
differentiation boosting of alveolar osteoblasts, thereby confirming current knowledge on the 12 
action of sodium fluoride on bone cells (Everett 2011, Lee et al. 2017). Of note, the effects 13 
seen in the present study originate from fluoride that was eluted from MTA disks, which 14 
means that fluoride-enriched MTA does release bioactive fluoride. Although the wash-out 15 
fluoride concentration was not determined, the  responses of osteoblasts unequivocally show 16 
that mitogenic and differentiation-inducing levels were present. With regard to the 17 
transcriptome, a peculiar finding was that fluoride affected the transcription of COMP, which 18 
is usually associated with enchondral ossification in long bones (Di Cesare et al. 2000) while 19 
being rarely described in alveolar osteoblasts. Obviously in the present study, the vast 20 
majority of genes modulated by MTA are related to osteogenic differentiation and 21 
extracellular matrix formation, while the effects of fluoride also covered the field of 22 
intercellular communication, growth factor and cytokine genes in skeletal development. This 23 
screening for transcriptional changes profoundly contributes to the understanding of the 24 
mechanisms of both MTA and fluoride actions on osteoblasts by disclosing single and 25 
combined effects of both substances. In addition to such cellular effects, fluoride 26 
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physicochemically interacts with bone mineral matrix by conversion of hydroxyapatite to 1 
fluorapatite (Everett 2011). Since both compounds contain equimolecular amounts of 2 
calcium, the intensified matrix mineralization presumably results from a real stimulation of 3 
osteogenic differentiation. This interpretation is emphasized by the finding that high-dose 4 
fluoride mainly affects the transcription of genes encoding for extracellular matrix proteins, 5 
reflecting the dose-related increase in matrix calcification. In clinical situations, local fluoride 6 
release has already been shown to enhance osteoblastic differentiation and bone formation 7 
(Cooper et al. 2006, Monjo et al. 2008); hence it can be speculated that similar effects are 8 
found for MTA containing fluoride in vivo. 9 
 10 
Conclusion 11 
The addition of sodium fluoride to ProRoot MTA cement supports the proliferation and 12 
differentiation of alveolar osteoblasts. Thus, fluoride enrichment opens up new horizons for 13 
the development of new MTA-based therapies that promote hard tissue formation in 14 
endodontics. 15 
16 
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Figure Captions 1 
Figure 1: Representative images (a) and surface roughness values (b) of non-fluoride MTA 2 
and fluoride-enriched MTA, respectively. (a) Laser scanning images, 3D surface roughness 3 
views and scanning electron microscopy images of MTA disks without fluoride (top row, 4 
H2O) or with the addition of 0.1% (second row), 0.25% (third row), or 0.5% fluoride (lower 5 
row) without (LSM and 3D views) and with alveolar osteoblasts, respectively. (b)  Sp: 6 
maximum profile peak height, Sv: maximum profile valley depth, Sz: maximum height of 7 
profile, Sa: arithmetic mean height, Sq: root mean square height, Ssk: skewness, Sku: kurtosis. 8 
Data are presented as mean±SD values. 9 
 10 
Figure 2: Bar graph diagrams showing the proliferation of osteoblasts undergoing incubation 11 
with eluates from non-fluoride MTA (H2O, black bars) and from fluoride-enriched MTA (0.1, 12 
0.25, 0.5, respectively, shaded bars) compared to MTA-free controls (w/o, white bars) at 1, 3, 13 
5, and 7 d. (a) Time-dependent proliferation change within the different groups and (b) inter-14 
group comparison at different time points.  15 
 16 
Figure 3: Osteogenic marker gene transcription (a) in osteoblasts incubated with eluates 17 
from non-fluoride MTA relative to MTA-free controls and (b) in all groups. (a) Volcano plots 18 
of qPCR data display statistical significance (y-axis) versus fold change (x-axis), respectively, 19 
with 1.5 as fold-change cutoff (vertical black lines) and p<0.05 (horizontal green line). Blue: 20 
down-regulated genes, grey: non-regulated genes, red: up-regulated genes. (b) Selection of 21 
genes which are modulated either by MTA or fluoride alone, or by a combination of both, 22 
respectively (see text for details). Fold regulation changes >2 are depicted in bold letters, and 23 
statistically significant changes are labeled with (*). 24 
 25 
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Figure 4: Compilation of qPCR data volcano plots of osteoblasts incubated with fluoride-1 
enriched MTA eluates relative to MTA-free controls (vs. w/o, a-c) and to cells incubated with 2 
non-fluoride MTA eluates (vs. H2O, d-e). The comparison of (a) with (d), (b) with (e), and (c) 3 
with (f) reveals fluoride-dependent changes is gene expression.  4 
Figure 5: Representative images of Alizarin red stains of MTA-free cells (a), and osteoblasts 5 
incubated with eluates from non-fluoride MTA (b), or MTA enriched with 0.1% (c), 0.25% 6 
(d), or 0.5% fluoride (e), respectively, after 21 d in culture without addition of further 7 
mineralization-inducing agents. (f) Box plot diagram of extracted Alizarin red dye of 8 
osteoblasts incubated with MTA eluates compared to MTA-free controls (w/o). 9 





